Page 6 - Script Biotech News Today

/PRNewswire/ -- The "Global Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer),...

/PRNewswire/ -- The "Global Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer),...

Exclusive agreement for region brings GenScripts innovative cPass™ kit to Spain, Portugal and Andorra LEIDEN, Netherlands & BILBAO, Spain--(BUSINESS WIRE)--GenScript Biotech (Netherlands) BV, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading biotechnology company, and IES Diagnostics, the Life Science division of IES Medical, a company based in Spain, announced they have signed an agreement for the exclusive distribution of the GenScript cPass�...

Press release content from Business Wire. The AP news staff was not involved in its creation. GenScript Biotech BV and IES Diagnostics Forge Distribution Agreement for SARS-CoV-2 Neutralizing Antibody Kit April 14, 2021 GMT LEIDEN, Netherlands & BILBAO, Spain--(BUSINESS WIRE)--Apr 14, 2021-- ADVERTISEMENT The test measures the presence of neutralizing antibodies (NAbs) in patients recovering from COVID-19 or receiving a vaccine. It is the only U.S. FDA Emergency Use Authorized (EUA) serology te...

Share this article Share this article ResearchAndMarkets.coms offering. The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a CAGR of 26.86% during the forecast. The development of genome engineering with potential applications proved to reflect a remarkable impact on the future of the healthcare and life science industry. The high efficiency of the CRISPR-Cas9 system has been demonstrated in various studies...